Autores
Lisa C Laan, Andrew R Williams, Kathrin Stavenhagen, Martin Giera, Gijs Kooij, Iliyan Vlasakov, Hakan Kalay, Helene Kringel, Peter Nejsum, Stig M Thamsborg, Manfred Wuhrer, Christine D Dijkstra, Richard D Cummings, Irma van Die
Fecha de publicación
2017
Revista
The FASEB Journal
Volumen
31
Número
2
Páginas
719-731
Editor
Federation of American Societies for Experimental Biology
Descripción
Clinical trials have shown that administration of the nematode Trichuris suis can be beneficial in treating various immune disorders. To provide insight into the mechanisms by which this worm suppresses inflammatory responses, an active component was purified from T. suis soluble products (TsSPs) that suppress TNF and IL‐12 secretion from LPS‐activated human dendritic cells (DCs). Analysis by liquid chromatography tandem mass spectrometry identified this compound as prostaglandin (PG)E2. The purified compound showed similar properties compared with TsSPs and commercial PGE2 in modulating LPS‐induced expression of many cytokines and chemokines and in modulating Rab7B and P2RX7 expression in human DCs. Furthermore, the TsSP‐induced reduction of TNF secretion from DCs is reversed by receptor antagonists for EP2 and EP4, indicating PGE2 action. T. suis secretes extremely high …
Artículos de Google Académico
LC Laan, AR Williams, K Stavenhagen, M Giera… - The FASEB Journal, 2017